We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.
- Authors
Huntington, Scott F.; Schuster, Stephen J.; Ding, Wei; Koehler, Amber B.; Brander, Danielle M.; Rosenthal, Allison C.; Leis, Jose F.; Tun, Han W.; Moustafa, Muhamad Alhaj; Iqbal, Madiha; He, Wei; Kearney, Albert S.; McKinlay, Timothy P.; Gui, Min; Mato, Anthony R.
- Publication
American Journal of Hematology, 2023, Vol 98, Issue 5, p739
- ISSN
0361-8609
- Publication type
Article
- DOI
10.1002/ajh.26888